pipette
ESEspañol

Provisional extracellular matrix signaling network regulates tumor lymphoneogenesis and response to immunotherapy

D. J. Lagal, D. Hong, A. Papadas, G. S. Yacu, E. Geatches, N. Leschinsky, Y. Huang, Y. Dou, M. Fields, A. Gibbons, E. Molina, K. Pestonjamasp, P. T. Toth, A. Cicala, J. Mamede, J. Schneider, K. Matkowskyj, D. A. Deming, S. Naik, F. A. Asimakopoulos

PreprintBold claims, read criticallyReal-world use

In the authors' words

Therapeutic induction of tumor tertiary lymphoid structures (TLS) represents an unmet need. ADAMTS-mediated proteolysis of the proteoglycan versican (VCAN), a cardinal provisional matrix modification in wound-healing, correlates with tumor T-cell inflammation. In human metastatic colorectal cancer, VCAN proteolysis prospectively predicted outcomes after checkpoint inhibition immunotherapy, with 100% overall-survival in the intense-proteolysis group at 4.1yr median follow-up. We now report that VCAN undergoes constitutive proteolysis within CXCL13-replete germinal center light zones in secondary lymphoid tissue, whereas inducible VCAN proteolysis localizes within CXCL13-rich tumor stromal niches. The VCAN matrikine, versikine, activates CD11b+ dendritic cells (DC) and expands cDC1 to organize TLS-archetypal triad hubs. Under permissive conditions of intact VCAN depletion, versikine-conditioned DC engage progenitor-exhausted CD8+ T-cells (Tpex) and Tpex-supporting, Th1-polarized CD4+ follicular-helper T-cells. Conversely, excess unproteolyzed VCAN favors DC-Treg crosstalk and Tpex loss from dysfunctional triads. Therapeutic versikine (mRNA/protein) eradicates experimental tumors modeling the VCAN-proteolysis-weak state of 60-73% of human colorectal cancers. Thus, tumor lymphoneogenesis co-opts a matrix-processing step of normal germinal center biology and wound-repair with prognostic and therapeutic implications.

Main resultThe abstract does not state a limitation.

Appeared: Wednesday, September 30. bioRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.09.24.753585